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Abstract
Type II endoleak is the most common complication after endovascular abdominal aortic aneurysm repair (EVAR). 
The management remains controversial. We present a case in which endoleak was successfully treated by direct per-
cutaneous thrombin injection with hydrodissection. This method seems to be a safe and feasible alternative method 
for treatment of type II endoleak. 
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Introduction
Endovascular abdominal aortic aneurysm repair (EVAR) 
is complicated by various types of endoleak in 10-50% 
of patients [1]. Type II endoleak is the most common, 
occurring in approximately 20% of cases [2,3]. How-
ever, management of type II endoleak remains contro-
versial. If the endoleak is accompanied by an aneurysm 
expansion (> 5 mm) and if it is persistent (> 6 months), 
an intervention should be considered [2]. A case in which 
the endoleak was successfully treated by direct percutane-
ous thrombin injection is presented in the article. Hydro-
dissection in the retroperitoneal space was utilised to 
form safe and sufficient access path to the aorta. To our 
knowledge, there is no published report regarding this ac-
cessory technique in percutaneous endoleak management.
Case report
An 86-year-old male patient was treated with EVAR due 
to a 62-mm infrarenal aortic aneurysm. The patient suf-
fered from coronary artery disease, arterial hypertension, 
general atherosclerosis, and benign prostatic hyper plasia 
accompanied by urolithiasis. Zenith stent-graft (Cook, 
Denmark) with suprarenal fixation was chosen to treat 
the aneurysm. Common iliac arteries were widened bi-
laterally, and therefore distal landing zones of the graft 
were set to the external iliac arteries. Control angiography 
following the procedure revealed no endoleak. Post-oper-
ative recovery was uneventful. 
A routine follow-up computed tomography (CT) scan 
performed one month post-operatively showed a signifi-
cant type II endoleak supplied by the inferior mesenteric 
artery. It did not thrombose until the follow-up CT per-
formed after six months. Subsequent imaging at one year 
depicted persistent endoleak with aneurysm sack enlarge-
ment to 68 mm.
The patient was re-admitted to the Department of 
Vascular Surgery in order to treat the persisting endoleak. 
The patient was initially scheduled to the Interventional 
Radiology Angio Suite for embolisation. Selective cathe-
terisation of the superior mesenteric artery was achieved 
from the femoral access, but further superselective ap-
proach to the origin of inferior mesenteric artery through 
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Figure 3. Control computed tomography after thrombin injection and needle 
removal- no persistent endoleak, no haemorrhagic complications, and no 
ureter injury
Figure 1. Axial computed tomography in prone position – endoleak type 2 
right-sided to the endograft (EL – endoleak, Ur – ureter, VCI – vena cava 
inferior)
Figure 2. A) Needle advanced close to vena cava inferior and the ureter – 
the space between the structures sufficiently splayed with an injection 
of 5% glucose in water (Glu – glucose in water, Ur – ureter, VCI – vena cava 
inferior). B) Needle tip in the endoleak zone, shortly before thrombin injec-
tion
A
B
the arc of Riolan was impossible. It was not possible to 
pass the vascular tortuosities to enable embolisation of 
the aneurysm sack and the origin of the inferior mes-
enteric artery (IMA) with the use of any microcatheters 
available in the angio suite (including neuromicrocath-
eters). Due to unsuccessful endovascular procedure, di-
rect puncture of the aneurysm sack was considered. The 
patient was scheduled to CT, settled in a prone position, 
and conscious sedation was administered. Initial scan 
with 60 ml of contrast agent in arterial and delayed phase 
was performed to re-evaluate the procedure planning 
process and the puncture site. Endoleak zone within the 
aneurysm sack was located right to the stent-graft; there-
fore, direct right retroperitoneal puncture was the safest 
and the only option to access the sack of the aneurysm 
(Figure 1). A 20-cm 18G biopsy needle was advanced be-
neath the lower pole of the right kidney and stopped at 
a short distance from the vena cava inferior. CT-fluoros-
copy was not available, so the needle was guided in a “scan 
and go” manner. After placing the tip of the needle in the 
area between ureter and vena cava inferior, approximately 
20 ml of 5% glucose was injected to achieve so-called hy-
drodissection in the retroperitoneal space in order to pro-
vide sufficient space for safe access to the aorta (Figure 2A). 
The needle was advanced gently to the aneurysm lumen 
until the backflow in the needle hub confirmed its cor-
rect position (Figure 2B). Subsequently, three ampules 
(1200 Units) of thrombin (Biothrombin, Poland) were 
injected to the lumen of the aneurysm. The needle was 
then retrieved. Post-procedural scan with 60 ml of con-
trast agent in arterial and delayed phase confirmed no 
signs of endoleak and no complications such as bleeding 
or damage of the vena cava inferior or ureter (Figure 3). 
Follow-up contrast-enhanced ultrasound (CEUS) at the 
end of hospital stay and at one month and six months 
confirmed no persistent endoleak (Figure 4). Aneurysm 
diameter at six months measured 66 mm.
Discussion
EVAR has evolved in recent decades. Nowadays, it is 
a commonly performed procedure used to treat abdom-
inal aortic aneurysm because it constitutes a minimally 
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invasive alternative to open repair. It is associated with 
a low rate of short-term and mid-term complications, 
although a long-term prognosis of EVAR is uncertain, 
mainly because of the endoleaks that represent a com-
mon complication after EVAR. By definition, the term 
“endoleak” denotes the persistence of blood flow outside 
the lumen of the graft but within the aneurysm sac [1,4,5].
Endoleaks can be classified into different types accord-
ing to the time of development (acute and late) and the or-
igin (types I-V). It is documented that types I and III are 
related with high risk of rupture [1], so urgent treatment 
is required. However, management of type II endoleaks 
remains controversial. This type of endoleak is, by defini-
tion, associated with retrograde flow into the aneurysm 
sac from arterial branches, commonly the inferior mesen-
teric or lumbar arteries [6]. Some researchers advocate in-
tervention in all cases, while others choose a conservative 
approach and believe that intervention is required only 
if the endoleak is accompanied by aneurysm expansion 
(> 5 mm) or it is persistent (> 6 months) [2]. According 
to the literature, up to 54% [4] of type II endoleaks resolve 
spontaneously. However, not all type II endoleaks are be-
nign; some of them can be associated with complications 
as aneurysm sac enlargement or even rupture [6]. 
Several options for the treatment are described in the 
literature, including transarterial approach or direct punc-
ture. Transarterial embolisation is the most commonly 
used approach, although there is evidence suggesting that 
the translumbar approach provides more stable results in 
the long-term [3] and enables shorter fluoroscopy and 
procedure time [7]. However, the proper management 
has to be adapted individually according to the location 
of the endoleak and the patient’s anatomy. In our case, 
anatomy made the transarterial approach impossible, so 
the translumbar approach was an effective alternative 
method.
Direct puncture of the endoleak can be performed 
using translumbar or transabdominal approach depend-
ing on the location of the endoleak. Direct percutaneous 
translumbar puncture and embolisation of left sided en-
doleaks have been described in literature [8]. A relatively 
large number of potential complications, including ret-
roperitoneal haemorrhage, inadvertent intracaval coil 
migration, or aortocaval fistula, makes the treatment of 
right-sided endoleaks more difficult. It is associated with 
the fact that the operator has to traverse the vena cava 
Figure 4. Follow-up contrast-enhanced ultrasound at six months – stent-
graft patent (PG), no endoleak visible
inferior. In the case described, the operator’s aim was to 
avoid a transcaval approach, so percutaneous injection of 
glucose with retroperitoneal hydrodissection of anatomi-
cal structures was performed. 
As reported in the literature, so-called hydrodissection 
plays a significant role in avoiding the potential damage of 
adjacent structures in procedures such as ablation or biop-
sy [9]. Depending on the procedure, 5% dextrose in water 
(D5W) or saline is used to promote safe needle access or 
to minimise potential damage of adherent organs. In our 
case hydrodissection was used to splay the space between 
the vena cava inferior and right ureter, which enabled safe 
access to the endoleak zone and its treatment by thrombin 
injection. Ultrasound-guided percutaneous thrombin in-
jection is commonly used for treatment of postcatheteri-
sation pseudoaneurysm because the therapy is quick, safe, 
well-tolerated, and cost-effective [10].
Conclusions
In the presented case, percutaneous direct thrombin in-
jection with hydrodissection seemed a safe and feasible 
alternative method for treatment of type II endoleak. 
Conflict of interest
The authors declare that they have no conflict of interest.
References
1. Rand T, Uberoi R, Cil B, et al. Quality Improvement Guidelines for 
Imaging Detection and Treatment of Endoleaks following Endo-
vascular Aneurysm Repair (EVAR). Cardiovasc Intervent Radiol 
2013; 36: 35-45.
2. Steinmetz E, Rubin BG, Sanchez LA, et al. Type II endoleak after 
endovascular abdominal aortic aneurysm repair: A conservative 
approach with selective intervention is safe and cost-effective. J Vasc 
Surg 2004; 39: 306-313.
3. Baum RA, Carpenter JP, Golden MA, et al. Treatment of type 2 en-
doleaks after endovascular repair of abdominal aortic aneurysm: 
Comparison of transarterial and translumbar techniques. J Vasc 
Surg 2002; 35: 23-29.
Bartosz Żabicki, Kinga Kubiak, Marcin Gabriel, Robert Juszkat  
e464 © Pol J Radiol 2018; 83: e461-e464
4. Sidloff DA, Stather PW, Choke E, et al. Type II endoleak after endo-
vascular aneurysm repair. Br J Surg 2013; 100: 1262-1270. 
5. White GH, Weiyun Y, May J, et al. Endoleak as a Complication of Endo-
luminal Grafting of Abdominal Aortic Aneurysm: Classification, Inci-
dence, Diagnosis and Management. J Endovasc Surg 1997; 4: 152-168. 
6. Stavropoulos SW, Park J, Fairman R, et al. Type 2 Endoleak Embo-
lization Comparison: Translumbar Embolization versus Modified 
Transarterial Embolization. J Vasc Interv Radiol 2009; 20: 1299-1302.
7. Yang RY, Tan KT, Beecroft JR, et al. Direct sac puncture versus tran-
sarterial embolization of type II endoleaks: An evaluation and com-
parison of outcomes. Vascular 2016; 25: 1-7. 
8. van den Berg JC, Nolthenius RP, Casparie JW, et al. CT-guided 
thrombin injection into aneurysm sac in a patient with endoleak 
after endovascular abdominal aortic aneurysm repair. AJR 2000; 
175: 1649-1651.
9. Asvadi NH, Arellano RS. Hydrodissection-Assisted Image-Guided 
Percutaneous Biopsy of Abdominal and Pelvic Lesions: Experience 
With Seven Patients. AJR 2015; 204: 865-867. 
10. La Perna L, Olin JW, Goines D, et al. Ultrasound-Guided Thrombin 
Injection for the Treatment of Postcatheterization Pseudoaneu-
rysms. Circulation 2000; 102: 2391-2395.
